Catalyst Wire Dossier Catalyst Wire Dossier

ASP7657

ASP7657 · Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP7657, covering 2015-03-27 to 2015-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects [Phase 1]

See pricing